drugset / Trial / NCT06103877
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers
RandomizedSequentialTriple-blindTreatment
Summary
A study to demonstrate the safety and tolerability of AZD1163 when administered intravenously and subcutaneously in healthy participants.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2026-01-13
- Completion
- 2026-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD1163 | Unknown | — | Intravenous |
Indications
No indication recorded.